– Reuters
Pulse Biosciences Shifts Core Technology Focus, Reduces Dermatologic Footprint
Bioelectric medicine company Pulse Biosciences Inc (NASDAQ:PLSE) announced a shift in focus to advance core NPS technology in the cardiac and oncology…
Related Posts
Florida’s Cannabis Market Shows Robust Growth: Analyst Examines Who’s On The Rise Amid Changing Landscape
The Florida cannabis market is experiencing impressive growth, setting the stage for the potential legalization of recreational use.
SOPHiA GENETICS And QIAGEN Forge Partnership To Combine Strengths In Next-generation Sequencing
SOPHiA GENETICS (NASDAQ:SOPH), a cloud-native software company in the healthcare space, today announced a new partnership with QIAGEN N.V. (NYSE:QGEN) that will pair QIAseq reagent technology with the SOPHiA